[Report No. 119–111]
January 23, 2025
Mrs. Blackburn (for herself, Mr. Van Hollen, Mrs. Capito, Mr. Blumenthal, Mr. Wicker, Ms. Blunt Rochester, and Mr. Luján) introduced the following bill; which was read twice and referred to the Committee on Commerce, Science, and Transportation
February 23, 2026
Reported by Mr. Cruz, with an amendment
Strike out all after the enacting clause and insert the part printed in italic
To amend the Office of National Drug Control Policy Reauthorization Act of 2006 to modify the authority of the Office of National Drug Control Policy with respect to the World Anti-Doping Agency, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
Section 1. Short title
This Act may be cited as the Restoring Confidence in the World Anti-Doping Agency Act of 2025
.
Sec. 2. Authority of National Drug Control Policy with respect to the World Anti-Doping Agency
Section 701 of the Office of National Drug Control Policy Reauthorization Act of 2006 (21 U.S.C. 2001) is amended—
(1)
in subsection (a)—
(A)
by amending paragraph (1) to read as follows:
(1) United States Olympic and Paralympic Committee
The term United States Olympic and Paralympic Committee means the organization established by chapter 2205 of title 36, United States Code.;
(B)
in paragraph (3), by striking (36 U.S.C. 22501(b)(1))
and inserting (36 U.S.C. 220501(b)(1))
;
(C)
by redesignating paragraphs (1) and (3) as paragraphs (4) and (1), respectively, and moving the paragraphs so as to appear in numeric order; and
(D)
by inserting after paragraph (2) the following:
(3) Independent athlete
The term independent athlete means an Olympic or Paralympic athlete who does not serve, in any capacity—
(A)
on the International Olympic Committee;
(B)
on the International Paralympic Committee;
(C)
at an international sports federation recognized by the International Olympic Committee or the International Paralympic Committee;
(D)
on the United States Olympic and Paralympic Committee; or
(E)
at the World Anti-Doping Agency.;
(2)
in subsection (b)—
(A)
by striking United States Olympic Committee
each place it appears and inserting United States Olympic and Paralympic Committee
;
(B)
in paragraph (5), by striking the period at the end and inserting ; and
; and
(C)
by adding at the end the following:
(6)
carry out responsibilities with respect to the World Anti-Doping Agency, as described in subsection (d).; and
(3)
by adding at the end the following:
(d) Authority with respect to the World Anti-Doping Agency
(1) In general
The Office of National Drug Control Policy, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Team USA Athletes’ Commission, shall—
(A)
use all available tools to ensure that—
(i)
the World Anti-Doping Agency has a credible and independent governance model that provides for fair representation of the United States;
(ii)
the World Anti-Doping Agency fully implements all governance reforms, including a proper conflict-of-interest policy for all members of the Executive Committee, the Foundation Board, and all relevant expert advisory groups, standing committees, permanent special committees, and working groups of the World Anti-Doping Agency; and
(iii)
independent athletes from the United States and other democratic countries, or representatives of such athletes, have decision-making roles on the Executive Committee and the Foundation Board, and in all relevant expert advisory groups, standing committees, permanent special committees, and working groups, of the World Anti-Doping Agency;
(B)
demonstrate leadership within the global community;
(C)
have strict standards that work toward countering doping in every form, including by countering systemic fraud through doping involving—
(i)
governmental law enforcement, intelligence, or anti-doping institutions;
(ii)
sporting organizations; or
(iii)
athlete support personnel; and
(D)
work collaboratively with democratic countries.
(2) Determination
(A) In general
Not later than 90 days after the date of the enactment of this subsection, the Office of National Drug Control Policy, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Team USA Athletes’ Commission, shall make a determination as to whether the World Anti-Doping Agency—
(i)
has a credible and independent governance model that provides for fair representation of the United States;
(ii)
fully implements all governance reforms, including a proper conflict-of-interest policy described in paragraph (1)(A)(ii); and
(iii)
allows independent athletes from the United States and other democratic countries, or representatives of such athletes, to have decision-making roles on the Executive Committee and the Foundation Board, and in all relevant expert advisory groups, standing committees, permanent special committees, and working groups, of the World Anti-Doping Agency.
(B) Accountability
In the case of a determination under subparagraph (A) that the World Anti-Doping Agency does not have such a governance model, has not fully implemented such governance reforms, or has not allowed decision-making roles described in clause (iii) of that subparagraph, the Office of National Drug Control Policy, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Team USA Athletes’ Commission, shall—
(i)
use all available tools to ensure that the United States has fair representation in the World Anti-Doping Agency, including—
(I)
on the Executive Committee;
(II)
on the Foundation Board; and
(III)
in all relevant expert advisory groups, standing committees, permanent special committees, and working groups of the World Anti-Doping Agency; and
(ii)
not later than 180 days after the date on which the determination under subparagraph (A) is made, issue a report that describes the barriers to participation and fair representation of the United States on the Executive Committee, the Foundation Board, and all relevant expert advisory groups, standing committees, permanent special committees, and working groups of the World Anti-Doping Agency.
(3) Voluntary nonpayment of dues
(A) In general
In the case of a determination under paragraph (2)(A) that the World Anti-Doping Agency does not have a governance model that provides for fair representation of the United States, has not fully implemented governance reforms, or has not allowed decision-making roles described in clause (iii) of that subparagraph, the Office of National Drug Control Policy, in consultation with the appropriate committees of Congress, may voluntarily withhold up to the full amount of membership dues to the World Anti-Doping Agency.
(B) Appropriate committees of Congress defined
In this paragraph, the term appropriate committees of Congress means—
(i)
the Subcommittee on Consumer Protection, Product Safety, and Data Security of the Committee on Commerce, Science, and Transportation of the Senate (or a successor subcommittee);
(ii)
the Subcommittee on Financial Services and General Government of the Committee on Appropriations of the Senate (or a successor subcommittee);
(iii)
the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce of the House of Representatives (or a successor subcommittee); and
(iv)
the Subcommittee on Financial Services and General Government of the Committee on Appropriations of the House of Representatives (or a successor subcommittee).
(4) Spending plan
Not later than 30 days before the Office of National Drug Control Policy obligates funds to the World Anti-Doping Agency, the Office of National Drug Control Policy shall submit to the Committee on Appropriations of the Senate and the Committee on Appropriations of the House of Representatives a spending plan and explanation of proposed uses of such funds.
Section 1. Short title
This Act may be cited as the Restoring Confidence in the World Anti-Doping Agency Act of 2025
.
Sec. 2. Authority of National Drug Control Policy with respect to the World Anti-Doping Agency
Section 701 of the Office of National Drug Control Policy Reauthorization Act of 2006 (21 U.S.C. 2001) is amended—
(1)
by striking subsection (a) and inserting the following:
(a) Definitions
In this subchapter:
(1) Amateur athlete
The term amateur athlete has the meaning given that term in section 220501(b)(1) of title 36, United States Code.
(2) Amateur athletic competition
The term amateur athletic competition has the meaning given that term in section 220501(b)(2) of title 36, United States Code.
(3) Independent athlete
The term independent athlete means a current or former amateur athlete who does not serve, in any capacity—
(A)
on the International Olympic Committee;
(B)
on the International Paralympic Committee;
(C)
at an international sports federation recognized by the International Olympic Committee or the International Paralympic Committee;
(D)
on the United States Olympic and Paralympic Committee;
(E)
at a national governing body (as defined in section 220501(b)(9) of title 36, United States Code); or
(F)
at the World Anti-Doping Agency.
(4) United States Olympic and Paralympic Committee
The term United States Olympic and Paralympic Committee means the organization established by chapter 2205 of title 36, United States Code.;
(2)
in subsection (b), by striking United States Olympic Committee
each place it appears and inserting United States Olympic and Paralympic Committee
; and
(3)
by adding at the end the following:
(d) Authority with respect to the World Anti-Doping Agency
(1) Annual determination
Not later than 180 days after the date of the enactment of this subsection, and annually thereafter, the Office of National Drug Control Policy, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Athletes’ Advisory Council (established and maintained under section 220504(b)(2)(A) of title 36, United States Code) shall make a determination as to whether the World Anti-Doping Agency—
(A)
has a credible and independent governance model that provides for fair representation of the United States;
(B)
fully implements or has implemented governance reforms to ensure independent governance; and
(C)
has fair processes and procedures to select independent athletes, including athletes from the United States and other democratic countries, or representatives of such athletes, for decision-making roles on the Executive Committee and the Foundation Board, and in all relevant expert advisory groups, standing committees, permanent special committees, and working groups of the World Anti-Doping Agency.
(2) Accountability
In the case of a determination under paragraph (1) that the World Anti-Doping Agency has not met the criteria set forth in subparagraphs (A), (B), or (C) of that paragraph, the Office of National Drug Control Policy, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Athletes’ Advisory Council (established and maintained under section 220504(b)(2)(A) of title 36, United States Code), shall use all available tools and best efforts to bring the World Anti-Doping Agency into compliance with the criteria set forth in that paragraph.
(3) Report
In the case of a determination under paragraph (1) that the World Anti-Doping Agency has not met the criteria set forth in subparagraphs (A), (B), or (C) of that paragraph, not later than 180 days after the date on which that determination is made, the Office of National Drug Control Policy, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Athletes’ Advisory Council (established and maintained under section 220504(b)(2)(A) of title 36, United States Code) shall submit to the appropriate committees of Congress a report that describes the barriers to participation and fair representation of the United States on the Executive Committee, the Foundation Board, and all relevant expert advisory groups, standing committees, permanent special committees, and working groups of the World Anti-Doping Agency.
(4) Voluntary nonpayment of dues
(A) In general
In the case of a determination under paragraph (1) that the World Anti-Doping Agency has not met the criteria set forth in subparagraphs (A), (B), or (C) of that paragraph, the Office of National Drug Control Policy, in consultation with the appropriate committees of Congress, may voluntarily withhold up to the full amount of any funds made available for the payment of the United States membership dues to the World Anti-Doping Agency.
(B) Return of funds after noncompliance
Unless otherwise specified by law, any funds made available for the payment of the United States membership dues to the World Anti-Doping Agency that have been voluntarily withheld pursuant to subparagraph (A) and have not been obligated prior to the end of an applicable fiscal year shall be returned to the general fund of the Treasury.
(5) Spending plan
Not later than 30 days before the Office of National Drug Control Policy obligates funds to the World Anti-Doping Agency, the Office of National Drug Control Policy shall submit to the appropriate committees of Congress a spending plan and explanation of proposed uses of such funds.
(6) Appropriate committees of Congress defined
In this subsection, the term appropriate committees of Congress means—
(A)
the Committee on Commerce, Science, and Transportation of the Senate;
(B)
the Committee on Appropriations of the Senate;
(C)
the Committee on Energy and Commerce of the House of Representatives; and
(D)
the Committee on Appropriations of the House of Representatives.